tetano
Editor, Senior Moderator
Int J Cardiovasc Imaging
. 2021 Feb 9.
doi: 10.1007/s10554-020-02139-2. Online ahead of print.
Contemporary use of cardiac imaging for COVID-19 patients: a three center experience defining a potential role for cardiac MRI
Ankur Panchal[SUP] 1 [/SUP], Andreas Kyvernitakis[SUP] 2 [/SUP], J Ronald Mikolich[SUP] 3 [/SUP], Robert W W Biederman[SUP] 4 [/SUP]
Affiliations
Abstract
The pandemic of coronavirus disease 2019 (COVID-19) secondary to the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has bestowed an unprecedented challenge upon us, resulting in an international public health emergency. COVID-19 has already resulted in > 1,600,000 deaths worldwide and the fear of a global economic collapse. SARS-CoV-2 is notorious for causing acute respiratory distress syndrome, however emerging literature suggests various dreaded cardiac manifestations associated with high mortality. The mechanism of myocardial damage in COVID-19 is unclear but thought to be multifactorial and mainly driven by the host's immune response (cytokine storm), hypoxemia and direct myocardial injury by the virus. Cardiac manifestations from COVID-19 include but are not limited to, acute myocardial injury, cardiac arrhythmias, congestive heart failure and acute coronary syndrome. Cardiac imaging is paramount to appropriately diagnose and manage the cardiac manifestations of COVID-19. Herein, we present cardiac imaging findings of COVID-19 patients with biomarker and imaging confirmed myocarditis to provide insight regarding the variable manifestations of COVID-19 myocarditis via Cardiac MRI (CMR) coupled with CMR-edema education along with recommendations on how to incorporate advanced CMR into the clinicians' COVID-19 armamentarium.
Keywords: COVID-19; Cardiac MRI; Coronavirus; SARS-CoV-2.
. 2021 Feb 9.
doi: 10.1007/s10554-020-02139-2. Online ahead of print.
Contemporary use of cardiac imaging for COVID-19 patients: a three center experience defining a potential role for cardiac MRI
Ankur Panchal[SUP] 1 [/SUP], Andreas Kyvernitakis[SUP] 2 [/SUP], J Ronald Mikolich[SUP] 3 [/SUP], Robert W W Biederman[SUP] 4 [/SUP]
Affiliations
- PMID: 33559800
- DOI: 10.1007/s10554-020-02139-2
Abstract
The pandemic of coronavirus disease 2019 (COVID-19) secondary to the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has bestowed an unprecedented challenge upon us, resulting in an international public health emergency. COVID-19 has already resulted in > 1,600,000 deaths worldwide and the fear of a global economic collapse. SARS-CoV-2 is notorious for causing acute respiratory distress syndrome, however emerging literature suggests various dreaded cardiac manifestations associated with high mortality. The mechanism of myocardial damage in COVID-19 is unclear but thought to be multifactorial and mainly driven by the host's immune response (cytokine storm), hypoxemia and direct myocardial injury by the virus. Cardiac manifestations from COVID-19 include but are not limited to, acute myocardial injury, cardiac arrhythmias, congestive heart failure and acute coronary syndrome. Cardiac imaging is paramount to appropriately diagnose and manage the cardiac manifestations of COVID-19. Herein, we present cardiac imaging findings of COVID-19 patients with biomarker and imaging confirmed myocarditis to provide insight regarding the variable manifestations of COVID-19 myocarditis via Cardiac MRI (CMR) coupled with CMR-edema education along with recommendations on how to incorporate advanced CMR into the clinicians' COVID-19 armamentarium.
Keywords: COVID-19; Cardiac MRI; Coronavirus; SARS-CoV-2.